Role for GDNF in Biochemical and Behavioral Adaptations to Drugs of Abuse

[1]  W. Tetzlaff,et al.  Promoting axonal regeneration in the central nervous system by enhancing the cell body response to axotomy , 2002, Journal of neuroscience research.

[2]  T. Joh,et al.  Regulation of tyrosine hyroxylase gene transcription in ventral midbrain by glial cell line‐derived neurotrophic factor , 1999, Synapse.

[3]  E. Nestler,et al.  Regulation of Phospholipase Cγ in the Mesolimbic Dopamine System by Chronic Morphine Administration , 1999, Journal of neurochemistry.

[4]  D. Surmeier,et al.  Expression of the transcription factor ΔFosB in the brain controls sensitivity to cocaine , 1999, Nature.

[5]  T. Robinson,et al.  Morphine alters the structure of neurons in the nucleus accumbens and neocortex of rats , 1999, Synapse.

[6]  E. Arenas,et al.  Differential Effects of Glial Cell Line‐Derived Neurotrophic Factor and Neurturin on Developing and Adult Substantia Nigra Dopaminergic Neurons , 1999, Journal of neurochemistry.

[7]  JaneR . Taylor,et al.  Enhancement of Locomotor Activity and Conditioned Reward to Cocaine by Brain-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[8]  J. Siuciak,et al.  Hippocampal mossy fiber sprouting induced by chronic electroconvulsive seizures , 1999, Neuroscience.

[9]  E. Nestler,et al.  Differential Regulation of Neurotrophin and trkReceptor mRNAs in Catecholaminergic Nuclei during Chronic Opiate Treatment and Withdrawal , 1998, The Journal of Neuroscience.

[10]  T. Joh,et al.  Regulation of Tyrosine Hydroxylase Promoter Activity by Chronic Morphine in TH9.0-LacZ Transgenic Mice , 1998, The Journal of Neuroscience.

[11]  F. Bloom,et al.  Neuroscience of Addiction , 1998, Neuron.

[12]  R. Wise.  Drug-activation of brain reward pathways. , 1998, Drug and alcohol dependence.

[13]  N. Belluardo,et al.  Multiple GPI-Anchored Receptors Control GDNF-Dependent and Independent Activation of the c-Ret Receptor Tyrosine Kinase , 1998, Molecular and Cellular Neuroscience.

[14]  J. Treanor,et al.  Characterization of Two Distinct Monoclonal Antibodies Specific for Glial Cell Line‐Derived Neurotrophic Factor , 1998, Journal of neurochemistry.

[15]  E. Nestler,et al.  Involvement of cAMP-Dependent Protein Kinase in the Nucleus Accumbens in Cocaine Self-Administration and Relapse of Cocaine-Seeking Behavior , 1998, The Journal of Neuroscience.

[16]  G. Gerhardt,et al.  Effects of glial cell line-derived neurotrophic factor on the nigrostriatal dopamine system in rodents and nonhuman primates. , 1998, Advances in pharmacology.

[17]  N. S. Pilotte.  Neurochemistry of cocaine withdrawal. , 1997, Current opinion in neurology.

[18]  T. Hagg,et al.  Glial cell line‐derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats , 1997, The Journal of comparative neurology.

[19]  B Kolb,et al.  Persistent Structural Modifications in Nucleus Accumbens and Prefrontal Cortex Neurons Produced by Previous Experience with Amphetamine , 1997, The Journal of Neuroscience.

[20]  G. Aghajanian,et al.  CREB (cAMP Response Element-Binding Protein) in the Locus Coeruleus: Biochemical, Physiological, and Behavioral Evidence for a Role in Opiate Dependence , 1997, The Journal of Neuroscience.

[21]  G. Aghajanian,et al.  Molecular and cellular basis of addiction. , 1997, Science.

[22]  M. Greenberg,et al.  FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[23]  R. Kalb,et al.  Sensitization to morphine induced by viral-mediated gene transfer. , 1997, Science.

[24]  G. Gerhardt,et al.  Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. , 1997, The Journal of pharmacology and experimental therapeutics.

[25]  N. Belluardo,et al.  Complementary and Overlapping Expression of Glial Cell Line-Derived Neurotrophic Factor (GDNF), c-ret Proto-Oncogene, and GDNF Receptor-α Indicates Multiple Mechanisms of Trophic Actions in the Adult Rat CNS , 1997, The Journal of Neuroscience.

[26]  A. Kelley,et al.  Enhanced reward‐related responding following cholera toxin infusion into the nucleus accumbens , 1997, Synapse.

[27]  C. Chiamulera,et al.  Common Neural Substrates for the Addictive Properties of Nicotine and Cocaine , 1997, Science.

[28]  A. Björklund,et al.  Short-Term GDNF Treatment Provides Long-Term Rescue of Lesioned Nigral Dopaminergic Neurons in a Rat Model of Parkinson’s Disease , 1996, The Journal of Neuroscience.

[29]  H. W. Harris,et al.  Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  N. Hiroi,et al.  Regulation of ERK ( Extracellular Signal Regulated Kinase), Part of the Neurotrophin Signal Transduction Cascade, in the Rat Mesolimbic Dopamine System by Chronic Exposure to Morphine or Cocaine , 1996, The Journal of Neuroscience.

[31]  A. Buj-Bello,et al.  Characterization of a multicomponent receptor for GDNF , 1996, Nature.

[32]  I. Fariñas,et al.  Renal and neuronal abnormalities in mice lacking GDNF , 1996, Nature.

[33]  Mart Saarma,et al.  Defects in enteric innervation and kidney development in mice lacking GDNF , 1996, Nature.

[34]  Jonas Frisén,et al.  Renal agenesis and the absence of enteric neurons in mice lacking GDNF , 1996, Nature.

[35]  E. Brodkin,et al.  Molecular mechanisms of drug addiction: adaptations in signal transduction pathways. , 1996, Molecular psychiatry.

[36]  E. Arenas,et al.  Functional receptor for GDNF encoded by the c-ret proto-oncogene , 1996, Nature.

[37]  Ted Abel,et al.  Recombinant BDNF Rescues Deficits in Basal Synaptic Transmission and Hippocampal LTP in BDNF Knockout Mice , 1996, Neuron.

[38]  E. Nestler,et al.  Induction of chronic Fos-related antigens in rat brain by chronic morphine administration. , 1996, Molecular pharmacology.

[39]  B. Hoffer,et al.  Functional recovery in parkinsonian monkeys treated with GDNF , 1996, Nature.

[40]  E. Nestler,et al.  Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  T. Bonhoeffer,et al.  Combination of gene targeting and gene transfer by adenoviral vectors in the analysis of neurotrophin-mediated neuronal plasticity. , 1996, Cold Spring Harbor symposia on quantitative biology.

[42]  E. Nestler,et al.  Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system , 1995, Synapse.

[43]  M. Kelz,et al.  Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. , 1995, The Journal of pharmacology and experimental therapeutics.

[44]  R. Duman,et al.  Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  E. Nestler,et al.  Influence of neurotrophic factors on morphine- and cocaine-induced biochemical changes in the mesolimbic dopamine system , 1995, Neuroscience.

[46]  E. Nestler,et al.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens , 1995, Brain Research.

[47]  R. Kvetňanský,et al.  Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[48]  D. Gash,et al.  GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo , 1995, Brain Research.

[49]  R. Vandlen,et al.  Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain , 1995, Nature.

[50]  David W. Self,et al.  Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments , 1994, Neuron.

[51]  James E. Smith,et al.  Chronic Cocaine Administration Increases CNS Tyrosine Hydroxylase Enzyme Activity and mRNA Levels and Tryptophan Hydroxylase Enzyme Activity Levels , 1993, Journal of neurochemistry.

[52]  E. Nestler,et al.  Drug addiction: A model for the molecular basis of neural plasticity , 1993, Neuron.

[53]  E. Nestler,et al.  Glial Fibrillary Acidic Protein and the Mesolimbic Dopamine System: Regulation by Chronic Morphine and Lewis‐Fischer Strain Differences in the Rat Ventral Tegmental Area , 1993, Journal of neurochemistry.

[54]  O. Lindvall,et al.  Rapid increase of BDNF mRNA levels in cortical neurons following spreading depression: regulation by glutamatergic mechanisms independent of seizure activity. , 1993, Brain research. Molecular brain research.

[55]  P. Kalivas,et al.  Time course of tyrosine hydroxylase expression after behavioral sensitization to cocaine. , 1993, The Journal of pharmacology and experimental therapeutics.

[56]  S. Cunningham,et al.  Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[57]  J. Lile,et al.  GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.

[58]  E. Nestler,et al.  Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[59]  U. Ungerstedt,et al.  Amphetamine regulation of mesolimbic dopamine/cholecystokinin neurotransmission , 1992, Brain Research.

[60]  E. Castrén,et al.  Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. Nestler,et al.  Morphine and Cocaine Exert Common Chronic Actions on Tyrosine Hydroxylase in Dopaminergic Brain Reward Regions , 1991, Journal of neurochemistry.

[62]  E. Nestler,et al.  A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function , 1991, Brain Research.

[63]  M. Takahashi,et al.  Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. , 1991, Oncogene.

[64]  C. Gall,et al.  Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. , 1989, Science.

[65]  B. Grafstein.  The nerve cell body response to axotomy , 1975, Experimental Neurology.

[66]  L. Geffen,et al.  Effects of axonal injury on norepinephrine, tyrosine hydroxylase and monoamine oxidase levels in sympathetic ganglia. , 1973, Journal of neurobiology.